Abstract:We investigated the clinical value of fractional flow reserve (FFR) for the prognostic evaluation of patients with percutaneous coronary intervention. We enrolled 120 patients who were admitted to the hospital to undergo percutaneous coronary intervention for acute coronary syndromes between May 2014 and June 2015. The 120 patients were divided into two groups, the observation group and the control group, according to the post-surgery level of FFR. Each cohort contained 60 patients. These patients were divided into the occurrence group (n=45) and the non-occurrence group (n=75), classified according to the occurrence of major adverse cardiovascular events (MACE). There were no statistically significant differences in the comparison of the occurrence rate of MACE within 30 days after surgery, such as lethal or non-lethal myocardial infarction or non-lethal cerebrovascular events, between the observational group and the control group (P>0.05). For the observation group, the 1-year survival cases were 56 with a survival rate of 93.3%, and 2-year survival cases were 50 with a survival rate of 83.3%. In the control group, the 1-year and 2-year survival cases were respectively 55 and 49 (survival rate of 91.7 and 81.7%). The occurrence rates of hyperlipidemia and ratio of patients with a history of smoking and drinking in the occurrence group were significantly higher than those in the non-occurrence group (P<0.05). The mean arterial pressure in the occurrence group was significantly higher than that in the non-occurrence group (P<0.05). Heart rate in the occurrence group is significantly faster than that in the non-occurrence group (P<0.05) and the stenosis degree in the occurrence group was significantly higher than that in the non-occurrence group (P<0.05). The left ventricular ejection fraction (LVEF) before surgery in the occurrence group was significantly lower than that in the non-occurrence group (P<0.05). There were no remarkable differences in comparison of the pre-treatment FFR between the occurrence group and the non-occurrence group (P>0.05), but the post-treatment FFR in the occurrence group was significantly lower than that in the non-occurrence group (P<0.05). Increased blood fat, a history of smoking and drinking, augmented mean arterial pressure, accelerated heart rate, severe coronary artery stenosis and the remarkably decreased LVEF were all identified as independent risk factors leading to major adverse myocardial events. The sum of specificity and sensitivity of treatment reached the peak when the post-surgery FFR was 0.875, the calculated sensitivity was 82.4%, and the specificity was 50.8%. In conclusion, measurement of FFR after percutaneous coronary intervention could not only effectively evaluate the target vessel revascularization, but also predict the occurrence of major adverse myocardial events 1 year after surgery, which could serve as the guidance for clinical treatment.

Clinical value of fractional flow reserve in coronary heart disease: A retrospective study

Estimating Current and Long-Term Risks of Coronary Artery in Silico by Fractional Flow Reserve, Wall Shear Stress and Low-Density Lipoprotein Filtration Rate

Comprehensive Assessment Of Coronary Fractional Flow Reserve

Effect of lesion characteristics on diagnostic performance of CT-derived fractional flow reserve: exploring the indications for application based on CT-FFR CHINA trial (Preprint)

Diagnostic Performance of Computational Fluid Dynamics (Cfd)-Based Fractional Flow Reserve (FFR) Derived from Coronary Computed Tomographic Angiography (CCTA) for Assessing Functional Severity of Coronary Lesions

The Guiding Significance of Fractional Flow Reserve (FFR) for Coronary Heart Disease Revascularization.

Fractional Flow Reserve Guided Percutaneous Coronary Intervention Improves Clinical Outcome with Reduced Cost in Contemporary Clinical Practice

Diagnostic Performance of Angiography-Based Fractional Flow Reserve for Functional Evaluation of Coronary Artery Stenosis

Analysis of the clinical value of fractional flow reserve for prognosis evaluation of patients of percutaneous coronary intervention.

Diagnostic Performance of Angiography-Based Fractional Flow Reserve for Functional Evaluation of Coronary Artery Stenosis.

Clinical Relevance of Coronary Fractional Flow Reserve

Fractional Flow Reserve Implications for Clinical Decision Making in Coronary Artery Disease

Clinical Relevance of Coronary Fractional Flow Reserve: Art-of-state.

Diagnostic Accuracy of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve

Virtual Fractional Flow Reserve Derived from Invasive Coronary Angiography

Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3‐vessel Fractional Flow Reserve Measurement

Diagnostic Performance of AccuFFRangio in the Functional Assessment of Coronary Stenosis Compared with Pressure Wire-Derived Fractional Flow Reserve.

Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

Abstract 10967: Prognostic Value of a Novel Index: Computational Pressure-Flow Dynamics Derived Fractional Flow Reserve in Stable Coronary Artery Disease Patients with Nonischemic Lesions

Accuracy of Computational Pressure-Fluid Dynamics Applied to Coronary Angiography to Derive Fractional Flow Reserve: FLASH FFR.

Image-based assessment of fractional flow reserve.